Emvistegrast
Emvistegrast is an investigational new drug that as of 2026 was being developed by Gilead Sciences for the treatment of ulcerative colitis.
≈ 1 min read
Emvistegrast. encyclopegia.org, snapshot enwiki-001365630466. /a/emvistegrast
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Emvistegrast is an investigational new drug that as of 2026 was being developed by Gilead Sciences for the treatment of ulcerative colitis. It is an integrin alpha4/beta7 antagonist.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1365630466 under CC BY-SA 4.0; modifications have been made.